These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7877428)

  • 1. [Bleeding peptic ulcers--how can recurrent bleeding be prevented?].
    Labenz J; Tillenburg B; Peitz U; Stolte M; Börsch G
    Leber Magen Darm; 1995 Jan; 25(1):27-33. PubMed ID: 7877428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
    Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
    Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
    Santander C; Grávalos RG; Gómez-Cedenilla A; Cantero J; Pajares JM
    Am J Gastroenterol; 1996 Aug; 91(8):1549-52. PubMed ID: 8759659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.
    Gisbert JP; Khorrami S; Carballo F; Calvet X; Gene E; Dominguez-Muñoz E
    Aliment Pharmacol Ther; 2004 Mar; 19(6):617-29. PubMed ID: 15023164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori increases the risk of peptic ulcer bleeding: a case-control study.
    Labenz J; Peitz U; Köhl H; Kaiser J; Malfertheiner P; Hackelsberger A; Börsch G
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):110-5. PubMed ID: 10363194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Helicobacter pylori infection and NSAIDs on the risk of peptic ulcer bleeding.
    Mahachai V; Thomson AB; Vilaichone RK
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S295-9. PubMed ID: 16083206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
    Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
    Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding.
    Gisbert JP; Calvet X; Feu F; Bory F; Cosme A; Almela P; Santolaria S; Aznárez R; Castro M; Fernández N; García-Grávalos R; Cañete N; Benages A; Montoro M; Borda F; Pérez-Aisa A; Piqué JM
    Helicobacter; 2007 Aug; 12(4):279-86. PubMed ID: 17669099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term consequences of Helicobacter pylori eradication: clinical aspects.
    Labenz J; Tillenburg B; Peitz U; Börsch G
    Scand J Gastroenterol Suppl; 1996; 215():111-5. PubMed ID: 8722393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Absence of bleeding recurrence of peptic ulcer after long term follow-up of successful eradication of Helicobacter pylori].
    Amendola M; Farias R; Katz J; Luna P; Ianella M; Musi A; Boerr L; Valero J; Kogan Z; Corti R
    Acta Gastroenterol Latinoam; 1999; 29(2):47-50. PubMed ID: 10491714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
    Labenz J; Börsch G
    Am J Gastroenterol; 1994 Oct; 89(10):1785-8. PubMed ID: 7942667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori and peptic ulcer disease.
    Blum AL
    Scand J Gastroenterol Suppl; 1996; 214():24-7; discussion 42-3. PubMed ID: 8722401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Audit of the change of outcome of peptic ulcer disease following treatment of Helicobacter pylori.
    Jost C; Marbet UA
    Schweiz Med Wochenschr; 1998 Jan; 128(3):64-71. PubMed ID: 9498257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers.
    Wong GL; Wong VW; Chan Y; Ching JY; Au K; Hui AJ; Lai LH; Chow DK; Siu DK; Lui YN; Wu JC; To KF; Hung LC; Chan HL; Sung JJ; Chan FK
    Gastroenterology; 2009 Aug; 137(2):525-31. PubMed ID: 19445937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.